Isocitrate Dehydrogenase 1 (<i>IDH1</i>) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate
Amir T. Fathi(University of Southern California), Darrell R. Borger(Massachusetts Eye and Ear Infirmary), Michaela J. Higgins(Cancer Trials Ireland), Meghan Burke(Harvard University), Amy Comander(Harvard University), David P. Schenkein(Agios Pharmaceuticals (United States)), Aditya Bardia(UCLA Health), Hossein Sadrzadeh(Boston University), Kimberly Straley(Agios Pharmaceuticals (United States)), Katharine Yen(Agios Pharmaceuticals (United States)), Sam Agresta(Agios Pharmaceuticals (United States)), Ashley Perry(Harvard University), Christina R. Matulis(Harvard University), Regina Silver(Harvard University), Hyeryun Kim(Agios Pharmaceuticals (United States))
Cited by 74
Related Papers
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k